Yaolin Wang is the founder of InventisBio. InventisBio has raised $166M in total funding. Latest round: Series D. Based in Shanghai, China.
Yaolin Wang is the Chairman and CEO of InventisBio, a clinical-stage biotech company focused on the research and development of innovative small molecule drugs for cancer and other major diseases. The company has secured significant funding, including a $147 million Series D financing led by Hillhouse affiliate GL Ventures and a $19 million Series B financing led by OrbiMed Asia. InventisBio has operations in China and the US, with drug candidates in various clinical stages for oncology and metabolic diseases. Wang co-founded InventisBio with scientists who have prior experience in drug discovery at Merck and Schering-Plough.
Full founder directory · Investor directory · Company funding database · Fundraising library